Financial insights of ADPT

MyFinsight

For the quarter ending 2026-03-31, ADPT made $70,874K in revenue. -$20,033K in net income. Net profit margin of -28.27%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	70,874	71,681	93,973	58,879
Cost of revenue	18,708	18,224	18,157	17,999
Research and development	23,623	21,763	23,669	24,134
Sales and marketing	26,346	24,481	23,470	23,573
General and administrative	20,984	19,557	17,959	17,786
Amortization of intangible assets	419	429	428	423
Impairment of long-lived assets	-	0	0	-
Total operating expenses	90,080	84,454	83,683	83,915
Loss from operations	-19,206	-12,773	10,290	-25,036
Interest and other income, net	2,080	2,148	2,226	2,391
Interest expense	2,889	2,954	2,971	2,948
Net loss	-20,015	-13,579	9,545	-25,593
Add net income attributable to noncontrolling interest	18	0	-1	21
Net loss attributable to adaptive biotechnologies corporation	-20,033	-13,579	9,546	-25,614

Basic EPS	-0.13	-0.089	0.06	-0.17
Diluted EPS	-0.13	-0.095	0.06	-0.17
Basic Average Shares	155,521,048	153,178,137	152,432,307	152,082,284
Diluted Average Shares	155,521,048	142,448,337	163,162,107	152,082,284

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.